Inactive Instrument

Calendar DelMar Pharmaceuticals Inc OTC Bulletin Board

Equities

DMPI

US2470781087

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for DelMar Pharmaceuticals Inc

Chart calendar DelMar Pharmaceuticals Inc

7fa78d485563bf3b220.8uy6QHki32f2fFm5kzue1F-9zD6T_TpBt16SxTu9-Lw.s9_reBoXi1K0SzHd-Q7JkzLivQegqn4u5zyn8GLZ1djAp8wVGA-oKa8aKg~57f39d5e09e83dd1bdee74bfd6ee20a5

Upcoming events on DelMar Pharmaceuticals Inc

2024-05-14 Q3 2024 Earnings Release (Projected)
2024-09-22 Q4 2024 Earnings Release (Projected)
2024-11-10 Q1 2025 Earnings Release (Projected)
2025-02-17 Q2 2025 Earnings Release (Projected)

Past events on DelMar Pharmaceuticals Inc

2024-04-03 08:30 am Business Update Call
2024-02-14 04:07 pm Q2 2024 Earnings Release
2023-11-13 04:10 pm Q1 2024 Earnings Release
2023-10-12 10:30 am Dawson James Small Cap Growth Conference
2023-10-09 12:00 pm Extraordinary Shareholders Meeting
2023-10-04 02:30 pm LD Micro Main Conference
2023-09-23 11:15 am European Association for Neuro Oncology Meeting - Abstract No: P11.41.B
2023-09-18 04:25 pm Q4 2023 Earnings Release
2023-08-21 11:00 am Investor Meeting - KOL
2023-08-09 12:00 pm Emerging Growth Conference
2023-07-18 Glioblastoma Awareness Day
2023-06-20 04:30 pm Maxim Group Virtual Healthcare Conference
2023-05-11 08:15 am Q3 2023 Earnings Release
2023-05-10 04:00 pm Sidoti Micro-Cap Virtual Conference
2023-05-08 12:00 pm Annual General Meeting
2023-05-03 01:00 pm Aegis Capital Virtual Conference
2023-04-17 01:30 pm American Association for Cancer Research Meeting - Abstract Number: LB126
2023-04-17 01:30 pm American Association for Cancer Research Meeting - Abstract Number: LB127
2023-04-17 01:30 pm American Association for Cancer Research Meeting - Poster Section: 34
2023-04-16 American Association for Cancer Research Meeting - Abstract Number: LB126

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00


0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00


0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-8,40
-7,25
-15.78%
-9,20
-7,39
-24.41%
-38,2
-31,2
-22.2%
0,00


-14,8
-14,6
-1.05%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,05
-7,22
-11.47%
-9,13
-7,30
-25.08%
-38,3
-39,3
2.47%
0,00


-14,6
-14,6
-0.62%
Net income
Million USD
Released
Forecast
Spread
-8,05
-7,22
-11.47%
-9,13
-7,37
-23.76%
-41,5
-41,1
-1.05%
-22,7


-15,0
-14,9
-0.62%
EPS
USD
Released
Forecast
Spread
-158
-143
-10.49%
-43,5
-29,0
-50%
-80,0
-66,6
-20.08%
-26,0


-9,27
-9,23
-0.43%
Announcement Date09/09/1918/09/2028/09/2127/09/2218/09/23

Quarterly results

Fiscal PeriodJune 2022 Q2 2022 Q3 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-



0,00
0,00
-



0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-5,90
-6,75
12.71%
-5,36
-6,73
20.39%



-3,50
-4,83
27.62%



-3,35
-3,25
-3.2%



Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,89
-6,72
12.35%
-5,36
-6,73
20.41%



-3,45
-4,83
28.55%



-3,34
-3,25
-2.77%



Net income
Million USD
Released
Forecast
Spread
-5,90
-6,76
12.82%
-5,36
-6,75
20.62%
-4,60


-3,45
-4,83
28.55%
-3,26


-3,34
-3,25
-2.84%



EPS
USD
Released
Forecast
Spread
-6,00
-8,67
30.77%
-5,50
-6,83
19.51%
-3,50


-2,10
-3,50
40%
-1,94


-1,95
-1,93
-1.04%



Announcement Date11/02/2213/05/2209/11/2214/02/2311/05/2318/09/23-
  1. Stock Market
  2. Equities
  3. KTRA Stock
  4. DMPI Stock
  5. Calendar DelMar Pharmaceuticals Inc